Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Renal cell tumors are increasingly recognized as heterogeneous diseases.
• Existing classifications require updates based on new molecular and pathological data.

Purpose of the Study:

• To review the updated 2016 World Health Organization (WHO) classification of renal cell tumors.
• To highlight new and emerging subtypes, focusing on molecular pathology and epidemiology.

Main Methods:

• Review of current literature and the 2016 WHO classification.
• Analysis of morphological, immunohistochemical, and molecular features.
• Examination of epidemiological data for renal cell tumors.

Main Results:

• The 2016 WHO classification incorporates new subtypes of renal cell tumors.
• Emphasis is placed on molecular pathological epidemiology for classification.
• Emerging and provisional renal cell carcinomas are included.

Conclusions:

• The updated WHO classification provides a framework for understanding renal cell tumor heterogeneity.
• Further revisions are necessary to achieve clinically meaningful classifications.
• Enhanced understanding of molecular characteristics is crucial for future advancements.